Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6060067 | Sleep Medicine | 2016 | 27 Pages |
Abstract
Sleep disturbances predominantly take the form of insomnia in patients with unipolar disorder, while patients with bipolar disorder show a decreased need for sleep. Sleep impairment in these patients is a risk factor for the development of a major depressive episode and suicidal behavior. Administration of second-generation antipsychotics (SGAs) olanzapine, quetiapine, and ziprasidone as augmentation therapy or monotherapy to unipolar and bipolar disorder patients, respectively, has been shown to improve sleep continuity and sleep architecture. Thus, their use by these patients could ameliorate their sleep disorder.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jaime M. Monti,